Spontaneous Bacterial Peritonitis Clinical Trial
Official title:
Diagnostic Performance of Different Scores for Predicting Spontaneous Bacterial Peritonitis in Cirrhotic Patients
This study aims at evaluating the diagnostic accuracy of serum procalcitonin, PEC index, modified Wehmeyer, and Mansoura scoring systems for SBP in cirrhotic patients with ascites
Based on clinical diagnosis, SBP is commonly underdiagnosed because of its nonspecific or asymptomatic presentation. Therefore, a diagnostic paracentesis should be performed in all cirrhotic patients with ascites who require emergency room care or hospitalization, who demonstrate signs/symptoms suggesting SBP, or who present gastrointestinal bleeding, in order to exclude SBP. Several non-invasive methods were tried in many studies for SBP diagnosis, as alternatives to diagnostic paracentesis, e.g., fecal calprotectin. Moreover, numerous scores were proposed for SBP diagnosis with variable accuracies, such as procalcitonin, ESR, and CRP (PEC) index, the modified Wehmeyer SBP scoring system, and Mansoura scoring system. This study aims at evaluating the diagnostic accuracy of serum procalcitonin, PEC index, modified Wehmeyer, and Mansoura scoring systems for SBP in cirrhotic patients with ascites. participants will be subjected to: Clinical evaluation: medical history and physical examination, Routine Laboratory investigations, Serum procalcitonin, Ascitic fluid study, Ascitic fluid culture with antibiotic sensitivity, Abdominal ultrasonography. The following scores will be calculated: Modified Child Pugh score, MELD score, MELD Na score, PEC index, Modified Wehmeyer score, and Mansoura score. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06026267 -
Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis
|
N/A | |
Withdrawn |
NCT02552862 -
Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)
|
Phase 3 | |
Completed |
NCT01193426 -
Diagnostic of Spontaneous Bacterial Peritonitis
|
||
Completed |
NCT02528097 -
A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
|
N/A | |
Completed |
NCT00359853 -
Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
|
Phase 4 | |
Active, not recruiting |
NCT04159870 -
Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis
|
Phase 3 | |
Completed |
NCT04153604 -
Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis
|
||
Completed |
NCT06234046 -
Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin
|
Phase 3 | |
Recruiting |
NCT01598870 -
Diagnosis of Spontaneous Bacterial Peritonitis
|
N/A | |
Recruiting |
NCT00761098 -
Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)
|
Phase 4 | |
Completed |
NCT05401721 -
Serum Copeptin in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
|
||
Completed |
NCT02468089 -
To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis
|
N/A | |
Not yet recruiting |
NCT04746937 -
Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis
|
Phase 3 | |
Recruiting |
NCT02759497 -
Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis
|
N/A | |
Completed |
NCT02608658 -
Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites
|
N/A | |
Completed |
NCT02388035 -
Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis
|
N/A | |
Completed |
NCT03163745 -
Asymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis
|
||
Completed |
NCT04273373 -
Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.
|
N/A | |
Active, not recruiting |
NCT04395365 -
Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis
|
Phase 3 | |
Terminated |
NCT00570960 -
Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis
|
Phase 4 |